Covid-19 vaccine update: What we know about Covovax and Serum Institute’s bridging study
For Covovax, SII will be testing the safety by using 1,600 participants in 19 sites. Recently, Adar Poonawalla, CEO of Serum Institute of India (SII) said that the company will soon be working on the bridging study of Covovax vaccine and stockpiling its doses from April this year. It is to note that Covovax is … Read more